Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Banner Corp
BANR
$2.39B
| $32.7M | ﹤0.01% |
602,699
+19,833
| +3% | +$1.12M |
|
1652
Century Communities
CCS
$1.91B
| $32.7M | ﹤0.01% |
490,766
+19,150
| +4% | +$1.35M |
|
|
WW
1653
DELISTED
WW International
WW
| $32.6M | ﹤0.01% |
902,783
+70,032
| +8% | +$2.4M |
|
1654
Coty
COTY
$2.42B
| $32.6M | ﹤0.01% |
3,492,464
-1,458,247
| -29% | -$13.2M |
|
1655
Axsome Therapeutics
AXSM
$11.2B
| $32.6M | ﹤0.01% |
483,250
+14,663
| +3% | +$880K |
|
1656
Carpenter Technology
CRS
$25.8B
| $32.5M | ﹤0.01% |
808,489
+41,072
| +5% | +$1.73M |
|
1657
Vroom Inc
VRM
$39M
| $32.5M | ﹤0.01% |
9,701
+547
| +6% | +$1.86M |
|
1658
HNI Corp
HNI
$3.24B
| $32.4M | ﹤0.01% |
737,135
+31,732
| +4% | +$1.38M |
|
1659
PBF Energy
PBF
$8.57B
| $32.4M | ﹤0.01% |
2,116,751
+51,385
| +2% | +$793K |
|
|
OCDX
1660
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $32.3M | ﹤0.01% |
1,507,356
+48,806
| +3% | +$992K |
|
1661
Repay Holdings
RPAY
$331M
| $32.3M | ﹤0.01% |
1,341,926
+150,009
| +13% | +$3.51M |
|
1662
Genworth Financial
GNW
$3.76B
| $32.1M | ﹤0.01% |
8,227,055
+99,336
| +1% | +$396K |
|
|
WWE
1663
DELISTED
World Wrestling Entertainment
WWE
| $32.1M | ﹤0.01% |
553,957
+6,109
| +1% | +$347K |
|
1664
Protagonist Therapeutics
PTGX
$8.79B
| $32M | ﹤0.01% |
713,838
+68,159
| +11% | +$2.25M |
|
1665
Allogene Therapeutics
ALLO
$649M
| $32M | ﹤0.01% |
1,228,081
+155,250
| +14% | +$4.43M |
|
1666
Array Technologies
ARRY
$803M
| $32M | ﹤0.01% |
2,048,555
+668,886
| +48% | +$14.1M |
|
1667
Smith & Wesson
SWBI
$651M
| $31.9M | ﹤0.01% |
920,336
-12,447
| -1% | -$261K |
|
1668
Hope Bancorp
HOPE
$1.79B
| $31.9M | ﹤0.01% |
2,251,808
+135,690
| +6% | +$2.06M |
|
1669
Dave & Buster's
PLAY
$377M
| $31.7M | ﹤0.01% |
780,905
+17,603
| +2% | +$762K |
|
1670
Granite Construction
GVA
$5.29B
| $31.6M | ﹤0.01% |
761,738
+20,252
| +3% | +$803K |
|
|
CVSA
1671
Covista Inc
CVSA
$4.25B
| $31.5M | ﹤0.01% |
885,095
+22,847
| +3% | +$857K |
|
1672
Opko Health
OPK
$985M
| $31.5M | ﹤0.01% |
7,781,918
+255,210
| +3% | +$1M |
|
1673
GrafTech
EAF
$175M
| $31.3M | ﹤0.01% |
269,718
+92,171
| +52% | +$11.6M |
|
1674
Community Health Systems
CYH
$393M
| $31.3M | ﹤0.01% |
2,026,204
+369,333
| +22% | +$5.02M |
|
1675
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| – | – |
0
| – | – |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.